Global Yttrium-90 Injection Market Strategic Research Report

Scope of the Report

The global Yttrium-90 Injection market size is predicted to grow from US$ 373 million in 2025 to US$ 800 million in 2032; it is expected to grow at a CAGR of 11.1% from 2026 to 2032.

In 2025, global Yttrium-90 Injection production reached approximately 7,776 units, with an average global market price of around US$49,000 per unit. Yttrium-90 (Y-90) injection is a targeted, minimally invasive form of internal radiation therapy (radioembolization) used to treat inoperable liver cancers. It involves injecting microscopic radioactive beads directly into the blood vessels supplying a tumor, allowing doctors to deliver high doses of radiation to destroy cancer cells while sparing healthy tissue.

Yttrium-90 Injection, as a category of nuclear medicine interventional therapy for liver tumors, presents a global market landscape with concentrated competition and high entry barriers. The number of commercialized products remains limited. First-mover manufacturers build solid barriers through long-term clinical accumulation and full-chain compliance qualifications, while new entrants need to overcome multiple regulatory and technical thresholds covering R&D, production, transportation and clinical implementation of radioactive drugs.

Continuous indication expansion acts as the core driver for market growth. Regulatory authorities in Europe and the US have gradually broadened product application scopes, covering colorectal cancer liver metastasis, primary hepatocellular carcinoma, intrahepatic cholangiocarcinoma and various liver metastatic tumors. The extension of treatment scenarios directly expands the target patient population and extends product lifecycle. Authoritative clinical guidelines in many countries include this therapy in recommendation systems, lifting clinical recognition and consolidating the foundation of market acceptance.

Regional markets show stratified development features. Mature markets in Europe and the US, with long application history and standardized diagnosis and treatment pathways, maintain steady growth. Emerging markets represented by China, which approved such products in recent years, enter the penetration stage of hospital access and clinical awareness cultivation, and show clear growth potential supported by medical insurance access policies.

Supply chain and medical supporting facilities form core constraints for market popularization. The radioactive attribute of products imposes strict requirements on production quality control, logistics distribution and hospital nuclear medicine facilities. Treatment delivery highly relies on collaboration between interventional and nuclear medicine departments, which limits coverage pace in lower-tier markets to some extent.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Yttrium-90 Injection market?

What factors are driving Yttrium-90 Injection market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Yttrium-90 Injection market opportunities vary by end market size?

How does Yttrium-90 Injection break out by Type, by Application?

This report presents a comprehensive overview of the global Yttrium-90 Injection market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Resin Microsphere Injection
• Glass Microsphere Injection
• Carbon Microsphere Injection

Segment by Application

• Liver Cancer
• Other Cancers and Diseases

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Yttrium-90 Injection market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Liver Cancer, Other Cancers and Diseases evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact